ArticleP & T : a peer-reviewed journal for formulary management2016

Panobinostat (Farydak): A Novel Option for the Treatment of Relapsed Or Relapsed and Refractory Multiple Myeloma.

Donald MoorePubMed ↗Full text ↗

No numbers read from the abstract.